Abstract
A large body of research including animal and human studies has confirmed the crucial role of the serotonin (5-HT) system in the regulation of anxiety-related behaviour and traits. In the past decade, the functional status of the 5-HT system in anxiety disorders has been regularly investigated by novel neuroimaging techniques, such as single-photon emission computed tomography (SPECT) and positron emission tomography (PET). Although these studies shed more light on several aspects of the 5-HT functioning in patients with anxiety disorders, the current knowledge about the specific role of the 5-HT system in particular anxiety phenotypes remains fragmentary. In this paper, we review the available data from SPECT and PET imaging studies of the 5-HT system in anxiety disorders, attempt to dissect the involvement of the 5-HT in neural circuits of anxiety and discuss some issues that need to be considered for further research in this area.
Keywords: Anxiety disorder, serotonin, PET, SPECT, neuroimaging
Current Pharmaceutical Design
Title:Neuroimaging of Serotonin System in Anxiety Disorders
Volume: 18 Issue: 35
Author(s): Eduard Maron, David Nutt and Jakov Shlik
Affiliation:
Keywords: Anxiety disorder, serotonin, PET, SPECT, neuroimaging
Abstract: A large body of research including animal and human studies has confirmed the crucial role of the serotonin (5-HT) system in the regulation of anxiety-related behaviour and traits. In the past decade, the functional status of the 5-HT system in anxiety disorders has been regularly investigated by novel neuroimaging techniques, such as single-photon emission computed tomography (SPECT) and positron emission tomography (PET). Although these studies shed more light on several aspects of the 5-HT functioning in patients with anxiety disorders, the current knowledge about the specific role of the 5-HT system in particular anxiety phenotypes remains fragmentary. In this paper, we review the available data from SPECT and PET imaging studies of the 5-HT system in anxiety disorders, attempt to dissect the involvement of the 5-HT in neural circuits of anxiety and discuss some issues that need to be considered for further research in this area.
Export Options
About this article
Cite this article as:
Maron Eduard, Nutt David and Shlik Jakov, Neuroimaging of Serotonin System in Anxiety Disorders, Current Pharmaceutical Design 2012; 18 (35) . https://dx.doi.org/10.2174/138161212803530844
DOI https://dx.doi.org/10.2174/138161212803530844 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Highlights on Medical Treatment of Uterine Fibroids
Current Pharmaceutical Design Individual Cell Longevity, ‘Life’s Timekeeper’, and Metazoan Evolution
Current Aging Science Estrogen, Neuroprotection and Neurogenesis after Ischemic Stroke
Current Drug Targets Neurohypophyseal Dysfunction During Septic Shock
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of the Brain Renin-Angiotensin System in Neurodegenerative Disorders
Current Alzheimer Research Review on the Protective Effects of PACAP in Models of Neurodegenerative Diseases In Vitro and In Vivo
Current Pharmaceutical Design Factors Influencing Body Mass Index, Appetite Control, and the Role of Glutamate and Excess Nutritional Protein During Child Development: A Review
Current Pediatric Reviews Implementation of a Biocircuit Implants for Neurotransmitter Release During Neuro-Stimulation
Current Neurovascular Research Interaction Between Bone and Muscle in Older Persons with Mobility Limitations
Current Pharmaceutical Design Adipobiology for Novel Therapeutic Approaches in Metabolic Syndrome
Current Vascular Pharmacology Pharmacotherapy of Obesity - Benefit, Bias and Hyperbole
Current Medicinal Chemistry Neuronutrient Amino-Acid Therapy Protects Against Reward Deficiency Syndrome: Dopaminergic Key to Homeostasis and Neuroplasticity
Current Pharmaceutical Design Ghrelin in Hypothalamic Regulation of Energy Balance
Current Topics in Medicinal Chemistry Mechanisms of Hormonal Regulation of Sertoli Cell Development and Proliferation: A Key Process for Spermatogenesis
Current Molecular Pharmacology Endometriosis: The Role of Pharmacotherapy
Current Women`s Health Reviews Tolvaptan: A New Therapeutic Agent
Reviews on Recent Clinical Trials Brainstem Neuropeptides and Vagal Protection of the Gastric Mucosal Against Injury: Role of Prostaglandins, Nitric Oxide and Calcitonin-Gene Related Peptide in Capsaicin Afferents
Current Medicinal Chemistry The Role of Melatonin in Pancreatic Protection: Could Melatonin be Used in the Treatment of Acute Pancreatitis?
Current Pharmaceutical Design The New Adipose Tissue and Adipocytokines
Current Diabetes Reviews Comparison Among Aerobic Exercise and Other Types of Interventions to Treat Depression: A Systematic Review
CNS & Neurological Disorders - Drug Targets